The Role of the Lysosomal Cl-/H+ Antiporter ClC-7 in Osteopetrosis and Neurodegeneration

Cells. 2022 Jan 21;11(3):366. doi: 10.3390/cells11030366.

Abstract

CLC proteins comprise Cl- channels and anion/H+ antiporters involved in several fundamental physiological processes. ClC-7 is a lysosomal Cl-/H+ antiporter that together with its beta subunit Ostm1 has a critical role in the ionic homeostasis of lysosomes and of the osteoclasts' resorption lacuna, although the specific underlying mechanism has so far remained elusive. Mutations in ClC-7 cause osteopetrosis, but also a form of lysosomal storage disease and neurodegeneration. Interestingly, both loss-of- and gain-of-function mutations of ClC-7 can be pathogenic, but the mechanistic implications of this finding are still unclear. This review will focus on the recent advances in our understanding of the biophysical properties of ClC-7 and of its role in human diseases with a focus on osteopetrosis and neurodegeneration.

Keywords: bone; chloride transport; lysosomal storage disease; lysosome; organellar transporter; osteoclast; osteopetrosis; proton transport.

Publication types

  • Review

MeSH terms

  • Antiporters / genetics
  • Antiporters / metabolism
  • Bone Resorption* / metabolism
  • Chloride Channels* / genetics
  • Chloride Channels* / metabolism
  • Humans
  • Lysosomal Storage Diseases* / metabolism
  • Lysosomes / metabolism
  • Osteopetrosis* / genetics
  • Osteopetrosis* / metabolism
  • Osteopetrosis* / pathology

Substances

  • Antiporters
  • CLCN7 protein, human
  • Chloride Channels